about
Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivoImmune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagentDeoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoEffect of immunostimulatory CpG-oligonucleotides in chronic lymphocytic leukemia B cells.DNA vaccines coding for heat-shock proteins (HSPs): tools for the activation of HSP-specific regulatory T cells.Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy.Development of vaccines against bovine tuberculosis.DNA vaccination and gene therapy: optimization and delivery for cancer therapy.ATF3 transcription factor and its emerging roles in immunity and cancerTowards effective non-viral gene delivery vector.Acute kidney injury and the potential for ATF3-regulated epigenetic therapy.Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.Identification of two subpopulations of purified human blood B cells, CD27- CD23+ and CD27high CD80+, that strongly express cell surface Toll-like receptor 9 and secrete high levels of interleukin-6.
P2860
Q24682799-85710B76-24BD-4119-92AB-EC7ED1BFD240Q28648083-18AD65B1-42D0-4EC2-9D2D-EAA7761B20C8Q33788621-7017B156-EA84-4444-8896-7C2C118138D0Q34431577-456AC657-11AB-4487-9013-555168D12508Q36150452-2F3E3CFD-202D-4C9F-BF85-1B12768C7ED5Q36316635-198B8F86-99A4-4786-8357-ADD42FBAFE93Q36492602-15801AEB-232A-4752-9D10-0A1BA99AF8DDQ37259636-5B5D9E33-F2F1-46BE-9F01-DE7C4922E47FQ37439129-921489BB-0C52-4F4C-AAD4-CE94F2B95941Q38830057-A9310C05-D896-449B-B0F8-2EE90D1D7C79Q39760231-C047576F-068C-4D42-A122-35C40C664550Q45420571-8F9E49F7-AB64-4318-92BD-9EADCBFC80DCQ51965126-E51A5DEE-A964-4DEB-84EF-17B6F71ACED8
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The role of CpG in DNA vaccines.
@ast
The role of CpG in DNA vaccines.
@en
The role of CpG in DNA vaccines.
@nl
type
label
The role of CpG in DNA vaccines.
@ast
The role of CpG in DNA vaccines.
@en
The role of CpG in DNA vaccines.
@nl
prefLabel
The role of CpG in DNA vaccines.
@ast
The role of CpG in DNA vaccines.
@en
The role of CpG in DNA vaccines.
@nl
P2093
P2860
P356
P1476
The role of CpG in DNA vaccines.
@en
P2093
McCluskie MJ
Weeratna RD
P2860
P2888
P304
P356
10.1007/S002810000014
P577
2000-01-01T00:00:00Z
P5875
P6179
1037529120